Additionally, the JAK-STAT pathway was activated as cytoplasmic SOCS3 immunostaining was significantly stronger in NASH than in NAFL (p < 0.001; Figure 2G–I). The gene discussed is SOCS3; the disease is metabolic dysfunction-associated steatohepatitis.